pnb-0408 dihexa clinical trial

pnb-0408 dihexa clinical trial human trials Dihexa (also known as PNB-0408) is an experimental small molecule derived from Dihexa 1mL(10 mM in DMSO)

Name: pnb-0408 dihexa clinical trial human trials Dihexa (also known as PNB-0408) is an experimental small molecule derived from Dihexa 1mL(10 mM in DMSO)
Brand: centoria.fr
SKU: 36879043598
Price: 25.38 USD
Availability: InStock
Rating: 4.3861 (5 reviews)

Dihexa 1mL(10 mM in DMSO) Neurotrophic Peptide Enhancer APExBIO dihexa human trial Dihexa (also known as PNB 0408) is an experimental small molecule derived from What if neuroplasticity research targeted the HGF c Met pathway? Dihexa (PNB 0408) is an angiotensin IVderived peptide studied in preclinical models for its role in synaptogenesis and cognitive signaling mechanisms. Human data remains limited. Dihexa 5mg Capsules (30 Count) Neurogenic & Synaptogenic #site_titleDihexa Canada: Ultra Pure Peptide for Synaptogenesis, Cognitive & Neuroregeneration Research

SKU: 36879043598 · From centoria.fr

4.4

USD25.38 USD73.38

Pay in 4 interest-free payments of $6.34 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

The peptides used at The T Clinic have been extensively researched and have strong safety profiles

Inhibition of miR-29b-3p or miR-378g upregulates NNMT expression and promotes osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs), whereas overexpression of miR-29b-3p or miR-378g downregulates NNMT expression and inhibits osteogenic differentiation of BMSCs